2 Stocks to Buy in a Biotech Crash
Biopharma stocks are starting to pull back in a big way. Flamel Technologies and Pfizer, though, are two good names to pick up on any weakness. Here's why.
Bristol-Myers Squibb Crushes First-Quarter Earnings: Here's Why
Bristol-Myers posts a much stronger first quarter than expected. Here's what investors need to know.